6MK.HM Merck & Co. Inc
- Market cap
- -
- P/E
- 155.1x
- P/B
- 8.68x
- ROE
- -26.6%
- Dividend yield
- 2.34%
- Fundamental score
- -
Ratios use the latest price and the current fiscal year annualized from 2 quarters up to Jun 2026.
Is 6MK.HM undervalued?
Graham numberThe Graham number of Merck & Co. Inc cannot be estimated reliably (it needs positive earnings and book value).
Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?
Merck & Co. Inc fundamental analysis
No fundamental analysis for Merck & Co. Inc yet.
Merck & Co. Inc stock price
Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.
Merck & Co. Inc financial statements
2026 annualized: Fiscal year 2026 is not finished. Income statement and cash flow are annualized from 2 quarters up to Jun 30, 2026, the balance sheet is the latest quarter. Figures change when the annual report is published.
Merck & Co. Inc annual financial statements (USD; K = thousand, M = million, B = billion, T = trillion)
| Item | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 Anlz |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Income Statement | |||||||||||
| Revenue | 39.8B | 40.1B | 42.3B | 46.8B | 41.5B | 48.7B | 59.3B | 60.1B | 64.2B | 65.0B | 65.8B |
| Gross Profit | 25.9B | 27.3B | 28.8B | 32.7B | 27.9B | 35.1B | 41.9B | 44.0B | 49.0B | 48.6B | 48.6B |
| Operating Income | 6.03B | 7.31B | 8.93B | 12.2B | 5.55B | 13.2B | 18.3B | 2.95B | 20.2B | 22.1B | -7.27B |
| EBITDA | - | 11.9B | 14.0B | 16.0B | 8.48B | - | 21.3B | 6.91B | 25.7B | 28.3B | -236M |
| Net Income | 3.92B | 2.39B | 6.22B | 9.84B | 7.07B | 13.0B | 14.5B | 365M | 17.1B | 18.3B | -11.2B |
| EPS | - | 0.89 | 2.40 | 3.88 | 2.79 | 5.16 | 5.72 | 0.14 | 6.77 | 7.38 | -4.52 |
| Balance Sheet | |||||||||||
| Total Assets | 95.4B | 87.9B | 82.6B | 84.4B | 91.6B | 106B | 109B | 107B | 117B | 137B | 130B |
| Total Liabilities | 55.1B | 53.3B | 55.8B | 58.4B | 66.2B | 67.4B | 63.1B | 69.0B | 70.7B | 84.2B | 87.8B |
| Shareholders' Equity | 40.1B | 34.3B | 26.7B | 25.9B | 25.3B | 38.2B | 46.0B | 37.6B | 46.3B | 52.6B | 41.9B |
| Cash & Short-term Investments | 6.52B | 6.09B | 7.97B | 9.68B | 8.05B | 8.10B | 12.7B | 6.84B | 13.2B | 14.6B | 6.85B |
| Cash Flow | |||||||||||
| Operating Cash Flow | 10.4B | 6.45B | 10.9B | 13.4B | 10.3B | 14.1B | 19.1B | 13.0B | 21.5B | 16.5B | 18.6B |
| Capital Expenditure | 1.61B | 1.89B | 2.62B | 3.47B | 4.43B | 4.45B | 4.39B | 3.86B | 3.37B | 4.11B | 3.77B |
| Free Cash Flow | - | 4.56B | 8.31B | 9.97B | 5.82B | 9.66B | 14.7B | 9.14B | 18.1B | 12.4B | 14.8B |
| Ratios | |||||||||||
| ROE | 9.8% | 7.0% | 23.3% | 38.0% | 27.9% | 34.2% | 31.6% | 1.0% | 37.0% | 34.7% | -26.6% |
| ROA | 4.1% | 2.7% | 7.5% | 11.7% | 7.7% | 12.3% | 13.3% | 0.3% | 14.6% | 13.3% | -8.6% |
| Net Profit Margin | 9.8% | 6.0% | 14.7% | 21.0% | 17.0% | 26.8% | 24.5% | 0.6% | 26.7% | 28.1% | -16.9% |
What these items mean
- Revenue
- Total sales of goods and services in the period.
- Gross Profit
- Revenue minus the direct cost of producing what was sold.
- Operating Income
- Profit from the core business after operating expenses.
- EBITDA
- Earnings before interest, taxes, depreciation and amortization.
- Net Income
- Profit left for shareholders after all expenses, interest and taxes.
- EPS
- Net income divided by shares outstanding.
- Total Assets
- Everything the company owns.
- Total Liabilities
- Everything the company owes.
- Shareholders' Equity
- Assets minus liabilities: the book value that belongs to shareholders.
- Cash & Short-term Investments
- Cash and investments that can be turned into cash quickly.
- Operating Cash Flow
- Cash generated by the core business.
- Capital Expenditure
- Cash spent on property, plant and equipment.
- Free Cash Flow
- Operating cash flow minus capital expenditure: cash left for dividends, buybacks or debt repayment.
- ROE
- Return on equity: net income divided by shareholders' equity.
- ROA
- Return on assets: net income divided by total assets.
- Net Profit Margin
- Net income as a share of revenue.
Merck & Co. Inc dividends
- Dividend yield
- 2.34%
- Forward dividend
- -
- Payout ratio
- 44.8%
- Ex-dividend date
- -
| Fiscal year | Dividends paid | Per share | Payout ratio |
|---|---|---|---|
| 2025 | USD 8.18B | 3.30 | 44.8% |
| 2024 | USD 7.84B | 3.10 | 45.8% |
| 2023 | USD 7.45B | 2.94 | 2,039.7% |
| 2022 | USD 7.01B | 2.76 | 48.3% |
| 2021 | USD 6.61B | 2.62 | 50.7% |
| 2020 | USD 6.22B | 2.46 | 87.9% |
| 2019 | USD 5.70B | 2.24 | 57.9% |
| 2018 | USD 5.17B | 1.99 | 83.2% |
| 2017 | USD 5.17B | 1.92 | 215.8% |
From the cash flow statement: dividends paid in the fiscal year, divided by that year's shares outstanding. Payout ratio = dividends paid / net income.
Who owns Merck & Co. Inc
Ownership data of Merck & Co. Inc is not available yet.
Merck & Co. Inc company profile
- Company name
- Merck & Co. Inc
- Ticker
- 6MK.HM
- Exchange
- Hamburg Exchange
- Sector
- Other
- Industry
- Metals & Mining
- Fiscal year end
- December
- Address
- Website
- -
About Merck & Co. Inc
There is no Profile data available for 6MK.HM.